Company: BSX
Filing Date: 2025-02-24
Form Type: 424B2
Source: 0001104659-25-016521
Chunk: 3

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-24
Form: 424B2
Chunk 3
---
| ​                                    | ​ | ​ | Page |   |    |   | ​ |
| ABOUT THIS PROSPECTUS                | ​ | ​ | ​    | ​ |  1 | ​ | ​ |
| WHERE YOU CAN FIND MORE INFORMATION  | ​ | ​ | ​    | ​ |  2 | ​ | ​ |
| FORWARD-LOOKING STATEMENTS           | ​ | ​ | ​    | ​ |  3 | ​ | ​ |
| RISK FACTORS                         | ​ | ​ | ​    | ​ |  4 | ​ | ​ |
| BOSTON SCIENTIFIC CORPORATION        | ​ | ​ | ​    | ​ |  5 | ​ | ​ |
| AMERICAN MEDICAL SYSTEMS EUROPE B.V. | ​ | ​ | ​    | ​ |  5 | ​ | ​ |
| USE OF PROCEEDS                      | ​ | ​ | ​    | ​ |  6 | ​ | ​ |
| DESCRIPTION OF DEBT SECURITIES       | ​ | ​ | ​    | ​ |  7 | ​ | ​ |
| PLAN OF DISTRIBUTION                 | ​ | ​ | ​    | ​ | 19 | ​ | ​ |
| LEGAL MATTERS                        | ​ | ​ | ​    | ​ | 21 | ​ | ​ |
| EXPERTS                              | ​ | ​ | ​    | ​ | 21 | ​ | ​ |

S-i

TABLE OF CONTENTS

### ABOUT THIS PROSPECTUS SUPPLEMENT
Unless otherwise indicated or unless the context otherwise requires, all references in this prospectus supplement to “we,” “us,” and “our” refer, collectively, to Boston Scientific Corporation and its consolidated subsidiaries and/or, where applicable, only to American Medical Systems Europe B.V. as the issuer of debt securities; the term “Boston Scientific” refers only to Boston Scientific Corporation, a Delaware corporation; and the term “AMS Europe” refers only to American Medical Systems Europe B.V., a private company with limited liability ( besloten vennootschap met beperkte aansprakelijkheid ) incorporated pursuant to the laws of the Netherlands and registered with the Dutch Chamber of Commerce under number 34185686.

This document consists of two parts. The first part is this prospectus supplement, which describes the specific terms of the notes AMS Europe is offering and other matters relating to AMS Europe and Boston Scientific. The second part is the accompanying prospectus, which provides more general